The landscape of dementia analysis has progressed drastically with the advent of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based checks that will detect Alzheimer's pathology decades just before indications emerge. Even though these technological innovations signify amazing development in comprehending neuro